Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bupivacaine liposome intercostal nerve block for postoperative analgesia after thoracoscopic thoracic surgery
ChiCTR2300076708Phase 4Recruiting
- Sponsor
- Southern Medical University
- Start
- Mar 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, single-blind trial of bupivacaine in postoperative pain (2 arms), sponsored by Southern Medical University. Primary endpoints: VAS pain scores at rest within 72 hours after surgery and VAS pain scores during cough within 72 hours after surgery. Started Mar 2023; status: recruiting.
02
Drugs
bupivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on ChiCTR2300076708.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300076708.